Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II

Author:

Leenders Ruben G. G.1ORCID,Brinch Shoshy Alam23,Sowa Sven T.4,Amundsen-Isaksen Enya23,Galera-Prat Albert4,Murthy Sudarshan4,Aertssen Sjoerd1,Smits Johannes N.1,Nieczypor Piotr1,Damen Eddy1,Wegert Anita1,Nazaré Marc5ORCID,Lehtiö Lari4ORCID,Waaler Jo23ORCID,Krauss Stefan23

Affiliation:

1. Symeres, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands

2. Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, 0317 Oslo, Norway

3. Department of Immunology and Transfusion Medicine, Oslo University Hospital, 0424 Oslo, Norway

4. Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, 90014 Oulu, Finland

5. Medicinal Chemistry, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Campus Berlin Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany

Funder

Sigrid Jus??liuksen S????ti??

Norges Forskningsr??d

Academy of Finland

Jane ja Aatos Erkon S????ti??

South-Eastern Norway Regional Health Authority

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3